company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 16:10:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,30992000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 16:10:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,30992000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 16:10:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,30992000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 16:10:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3673000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 16:10:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,32146000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 16:10:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,35819000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 16:10:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4827000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 16:10:26+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3155000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 16:10:26+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,4290000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 16:10:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1135000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 16:10:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3692000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 16:10:26+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-11000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 16:10:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3681000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 16:10:26+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,94000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 16:10:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3587000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 16:10:26+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-857000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 16:10:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2730000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 16:10:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,98116000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 16:10:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.03
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 16:10:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,98116000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 16:10:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.03
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 16:10:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,91000000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 16:10:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.03
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2009.0,Q3,2009-07-01,2009-09-30,2010-11-04 17:37:51+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,26771000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2009.0,Q3,2009-07-01,2009-09-30,2010-11-04 17:37:51+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,26771000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2009.0,Q3,2009-07-01,2009-09-30,2010-11-04 17:37:51+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,26771000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2009.0,Q3,2009-07-01,2009-09-30,2010-11-04 17:37:51+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3335000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2009.0,Q3,2009-07-01,2009-09-30,2010-11-04 17:37:51+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,33832000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2009.0,Q3,2009-07-01,2009-09-30,2010-11-04 17:37:51+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,37167000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2009.0,Q3,2009-07-01,2009-09-30,2010-11-04 17:37:51+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10396000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2009.0,Q3,2009-07-01,2009-09-30,2010-11-04 17:37:51+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3185000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2009.0,Q3,2009-07-01,2009-09-30,2010-11-04 17:37:51+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1553000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2009.0,Q3,2009-07-01,2009-09-30,2010-11-04 17:37:51+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1632000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2009.0,Q3,2009-07-01,2009-09-30,2010-11-04 17:37:51+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12028000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2009.0,Q3,2009-07-01,2009-09-30,2010-11-04 17:37:51+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,724000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2009.0,Q3,2009-07-01,2009-09-30,2010-11-04 17:37:51+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12752000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2009.0,Q3,2009-07-01,2009-09-30,2010-11-04 17:37:51+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,34000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2009.0,Q3,2009-07-01,2009-09-30,2010-11-04 17:37:51+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12718000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2009.0,Q3,2009-07-01,2009-09-30,2010-11-04 17:37:51+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-1136000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2009.0,Q3,2009-07-01,2009-09-30,2010-11-04 17:37:51+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11582000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2009.0,Q3,2009-07-01,2009-09-30,2010-11-04 17:37:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,98320000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2009.0,Q3,2009-07-01,2009-09-30,2010-11-04 17:37:51+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.12
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2009.0,Q3,2009-07-01,2009-09-30,2010-11-04 17:37:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,98320000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2009.0,Q3,2009-07-01,2009-09-30,2010-11-04 17:37:51+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.12
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2009.0,Q3,2009-07-01,2009-09-30,2010-11-04 17:37:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,96500000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2009.0,Q3,2009-07-01,2009-09-30,2010-11-04 17:37:51+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.12
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 18:11:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,29926000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 18:11:57+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,29926000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 18:11:57+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,29926000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 18:11:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2819000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 18:11:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,31987000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 18:11:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,34806000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 18:11:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4880000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 18:11:57+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3237000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 18:11:57+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-1541000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 18:11:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4778000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 18:11:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9658000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 18:11:57+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 18:11:57+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,9658000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 18:11:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,0.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 18:11:57+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,0.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 18:11:57+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 18:11:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,99013000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 18:11:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.1
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 18:11:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,99013000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 18:11:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.1
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 18:11:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.1
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 20:02:03+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,23503000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 20:02:03+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,23503000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 20:02:03+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,23503000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 20:02:03+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3051000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 20:02:03+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,39124000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 20:02:03+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,42175000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 20:02:03+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-18672000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 20:02:03+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3261000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 20:02:03+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-3219000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 20:02:03+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6480000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 20:02:03+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-25152000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 20:02:03+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 20:02:03+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,25154000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 20:02:03+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,0.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 20:02:03+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,0.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 20:02:03+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 20:02:03+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,99091000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 20:02:03+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.25
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 20:02:03+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,99091000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 20:02:03+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.25
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q2,2010-04-01,2010-06-30,2011-08-05 20:02:03+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.25
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 18:15:45+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,28624000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 18:15:45+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,28624000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 18:15:45+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,28624000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 18:15:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2855000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 18:15:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,34716000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 18:15:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,37571000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 18:15:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8947000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 18:15:45+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3338000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 18:15:45+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-169000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 18:15:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3507000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 18:15:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12454000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 18:15:45+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 18:15:45+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,12454000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 18:15:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,0.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 18:15:45+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,0.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 18:15:45+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 18:15:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,99196000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 18:15:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.13
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 18:15:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,99196000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 18:15:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.13
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 18:15:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.13
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q4,2010-10-01,2010-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,26420000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q4,2010-10-01,2010-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,26420000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,26420000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2944000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,39333000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,42277000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q4,2010-10-01,2010-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15857000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3396000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,707000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,4651000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q4,2010-10-01,2010-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1962000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13895000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,90000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-47266000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q4,2010-10-01,2010-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-61251000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q4,2010-10-01,2010-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-61251000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q4,2010-10-01,2010-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-61251000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q4,2010-10-01,2010-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,99143000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q4,2010-10-01,2010-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.48
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q4,2010-10-01,2010-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,99143000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q4,2010-10-01,2010-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.14
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q4,2010-10-01,2010-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,98800000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2010.0,Q4,2010-10-01,2010-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.14
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 18:43:43+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,21147000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 18:43:43+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,21147000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 18:43:43+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,21147000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 18:43:43+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3010000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 18:43:43+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,34245000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 18:43:43+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,37255000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 18:43:43+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-16108000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 18:43:43+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3415000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 18:43:43+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-469000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 18:43:43+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3884000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 18:43:43+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-19992000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 18:43:43+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 18:43:43+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,19994000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 18:43:43+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,0.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 18:43:43+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,0.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 18:43:43+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,0.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 18:43:43+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 18:43:43+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,99569000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 18:43:43+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 18:43:43+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,99569000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 18:43:43+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 18:43:43+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.2
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 13:26:35+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,24823000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 13:26:35+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,24823000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 13:26:35+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,24823000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 13:26:35+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2874000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 13:26:35+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,36009000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 13:26:35+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,38883000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 13:26:35+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14060000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 13:26:35+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3437000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 13:26:35+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-383000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 13:26:35+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3820000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 13:26:35+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17880000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 13:26:35+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,9000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 13:26:35+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,17889000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 13:26:35+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,0.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 13:26:35+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,0.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 13:26:35+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,0.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 13:26:35+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 13:26:35+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,99602000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 13:26:35+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 13:26:35+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,99602000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 13:26:35+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 13:26:35+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.18
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:02:13+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,20713000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:02:13+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,20713000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:02:13+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,20713000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:02:13+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3105000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:02:13+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,39924000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:02:13+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,43029000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:02:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-22316000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:02:13+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4773000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:02:13+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,207000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:02:13+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4566000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:02:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-26882000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:02:13+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:02:13+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,26882000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:02:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,0.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:02:13+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,0.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:02:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,0.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:02:13+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:02:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,99687000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:02:13+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:02:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,99687000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:02:13+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:02:13+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.27
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,32403000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,32403000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,32403000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3800000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,47219000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,51019000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-18616000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5107000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3687000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1420000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-20036000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-64765000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-84801000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-84801000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-84801000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,99656000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.85
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,99656000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.85
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,99800000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.2
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 15:57:15+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,23235000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 15:57:15+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,23235000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 15:57:15+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,23235000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 15:57:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2976000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 15:57:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,38714000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 15:57:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,41690000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 15:57:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-18455000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 15:57:15+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5179000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 15:57:15+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-359000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 15:57:15+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 15:57:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5538000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 15:57:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-23993000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 15:57:15+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 15:57:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23995000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 15:57:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23995000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 15:57:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-23995000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 15:57:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,100157000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 15:57:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.24
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 15:57:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,100157000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 15:57:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.24
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 15:57:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,100000000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 15:57:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.24
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 14:42:15+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,47340000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 14:42:15+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,47340000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 14:42:15+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,47340000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 14:42:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3209000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 14:42:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,40435000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 14:42:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,43644000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 14:42:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3696000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 14:42:15+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5219000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 14:42:15+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,316000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 14:42:15+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 14:42:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4903000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 14:42:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1207000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 14:42:15+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 14:42:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1207000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 14:42:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1207000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 14:42:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1207000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 14:42:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,100213000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 14:42:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.01
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 14:42:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,100213000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 14:42:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.01
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 14:42:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,120700000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 14:42:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.01
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:29:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11601000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:29:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11601000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:29:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11601000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:29:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3096000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:29:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,36551000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:29:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,39647000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:29:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-28046000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:29:27+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10707000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:29:27+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,408000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:29:27+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:29:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10299000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:29:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-38345000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:29:27+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-706000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:29:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-37639000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:29:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-37639000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:29:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-37639000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:29:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,100680000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:29:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.37
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:29:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,100680000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:29:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.37
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:29:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,101700000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 17:29:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.37
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,19873000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,19873000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,19873000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3234000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,42758000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,45992000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-26119000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4817000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1538000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,18356000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,15077000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11042000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-8405000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2637000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2637000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2637000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,100700000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.03
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,100700000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.03
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,100576000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.03
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 14:17:52+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,43360000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 14:17:52+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,43360000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 14:17:52+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,43360000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 14:17:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3423000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 14:17:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,38312000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 14:17:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,41735000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 14:17:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1625000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 14:17:52+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4795000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 14:17:52+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1434000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 14:17:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3361000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 14:17:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1736000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 14:17:52+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-64000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 14:17:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1672000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 14:17:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1672000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 14:17:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1672000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 14:17:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,83600000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 14:17:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.02
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 14:17:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,83600000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 14:17:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.02
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 14:17:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,101875000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 14:17:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.02
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 15:24:14+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,38092000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 15:24:14+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,38092000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 15:24:14+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,38092000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 15:24:14+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3389000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 15:24:14+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,42631000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 15:24:14+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,46020000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 15:24:14+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7928000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 15:24:14+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4808000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 15:24:14+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1429000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 15:24:14+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3379000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 15:24:14+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11307000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 15:24:14+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1181000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 15:24:14+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10126000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 15:24:14+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10126000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 15:24:14+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10126000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 15:24:14+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,112500000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 15:24:14+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.09
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 15:24:14+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,112500000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 15:24:14+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.09
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 15:24:14+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,108539000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 15:24:14+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.09
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:56:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,23585000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:56:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,23585000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:56:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,23585000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:56:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3430000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:56:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,45660000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:56:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,49090000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:56:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-25505000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:56:54+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4867000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:56:54+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,609000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:56:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4258000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:56:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-29763000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:56:54+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-5193000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:56:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24570000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:56:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24570000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:56:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-24570000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:56:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,117000000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:56:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.21
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:56:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,117000000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:56:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.21
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:56:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,115263000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 16:56:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.21
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,42248000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,42248000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,42248000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4676000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,57430000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,62106000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-19858000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4885000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,991000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3894000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-23752000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,524000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24276000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24276000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-24276000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,110300000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.23
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,110300000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.23
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,110502000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.23
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 16:53:41+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,28161000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 16:53:41+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,28161000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 16:53:41+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,28161000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 16:53:41+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4380000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 16:53:41+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,53448000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 16:53:41+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,57828000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 16:53:41+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-29667000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 16:53:41+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4943000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 16:53:41+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1054000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 16:53:41+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3889000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 16:53:41+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-33556000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 16:53:41+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-2276000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 16:53:41+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-31280000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 16:53:41+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-31280000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 16:53:41+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-31280000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 16:53:41+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,115900000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 16:53:41+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.27
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 16:53:41+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,115900000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 16:53:41+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.27
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 16:53:41+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,117128000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 16:53:41+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.27
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 18:31:43+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,57076000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 18:31:43+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,57076000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 18:31:43+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,57076000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 18:31:43+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4462000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 18:31:43+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,59264000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 18:31:43+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,63726000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 18:31:43+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6650000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 18:31:43+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4961000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 18:31:43+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,411000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 18:31:43+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4550000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 18:31:43+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11200000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 18:31:43+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,881000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 18:31:43+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12081000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 18:31:43+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12081000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 18:31:43+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12081000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 18:31:43+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,117588000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 18:31:43+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.1
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 18:31:43+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,117588000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 18:31:43+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.1
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 18:31:43+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,120800000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 18:31:43+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.1
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:41:38+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,44063000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:41:38+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,44063000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:41:38+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,44063000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:41:38+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4470000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:41:38+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,61086000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:41:38+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,65556000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:41:38+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-21493000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:41:38+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4998000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:41:38+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1213000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:41:38+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3785000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:41:38+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-25278000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:41:38+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1398000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:41:38+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-26676000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:41:38+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-26676000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:41:38+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-26676000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:41:38+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,116000000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:41:38+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.23
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:41:38+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,116000000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:41:38+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.23
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:41:38+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,117811000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:41:38+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.23
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,84861000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,84861000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,84861000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6828000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,67953000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,74781000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,10080000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,15599000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,21162000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,5563000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,15643000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-15410000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,31053000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,31053000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,31053000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,118100000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.27
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,118100000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.27
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,117691000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.27
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 18:34:40+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,62583000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 18:34:40+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,62583000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 18:34:40+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,62583000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 18:34:40+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7466000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 18:34:40+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,64447000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 18:34:40+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,71913000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 18:34:40+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9330000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 18:34:40+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9021000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 18:34:40+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,845000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 18:34:40+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8176000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 18:34:40+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17506000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 18:34:40+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-789000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 18:34:40+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16717000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 18:34:40+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16717000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 18:34:40+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16717000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 18:34:40+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,119400000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 18:34:40+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.14
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 18:34:40+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,119400000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 18:34:40+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.14
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 18:34:40+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,118948000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 18:34:40+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.14
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:52:50+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,120428000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:52:50+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,120428000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:52:50+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,120428000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:52:50+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7775000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:52:50+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,68007000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:52:50+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,75782000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:52:50+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,44646000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:52:50+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9127000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:52:50+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,918000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:52:50+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8209000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:52:50+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,36437000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:52:50+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,789000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:52:50+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,35648000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:52:50+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,35648000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:52:50+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,35648000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:52:50+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,119742000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:52:50+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.3
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:52:50+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,127779000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:52:50+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.29
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:52:50+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,118800000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:52:50+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.3
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 15:57:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,49121000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 15:57:16+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,49121000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 15:57:16+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,49121000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 15:57:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8751000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 15:57:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,88508000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 15:57:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,97259000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 15:57:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-48138000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 15:57:16+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9233000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 15:57:16+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,21595000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 15:57:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,12362000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 15:57:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-35776000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 15:57:16+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 15:57:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-35776000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 15:57:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-35776000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 15:57:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-35776000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 15:57:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,119979000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 15:57:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.3
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 15:57:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,119979000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 15:57:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.3
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 15:57:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,119300000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 15:57:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.3
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,51571000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,51571000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,51571000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,13181000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,101330000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,114511000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-62940000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9351000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1230000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8121000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-71061000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,372000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-71433000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-71433000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-71433000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,119719000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.6
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,119719000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.59
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,119300000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.6
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:10:20+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,36874000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:10:20+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,36874000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:10:20+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,36874000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:10:20+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10562000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:10:20+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,80964000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:10:20+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,91526000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:10:20+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-54652000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:10:20+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9490000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:10:20+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1457000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:10:20+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:10:20+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8033000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:10:20+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-62685000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:10:20+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,232000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:10:20+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-62917000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:10:20+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-62917000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:10:20+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-62917000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:10:20+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,120598000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:10:20+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.52
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:10:20+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,120598000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:10:20+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.52
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:10:20+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,121000000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:10:20+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.52
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:50:14+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,38470000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:50:14+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,38470000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:50:14+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,38470000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:50:14+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9824000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:50:14+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,77573000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:50:14+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,87397000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:50:14+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-48927000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:50:14+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9625000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:50:14+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1466000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:50:14+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:50:14+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8159000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:50:14+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-57086000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:50:14+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-231000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:50:14+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-56855000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:50:14+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-56855000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:50:14+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-56855000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:50:14+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,121000000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:50:14+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.47
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:50:14+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,121000000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:50:14+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.47
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:50:14+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,120798000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 17:50:14+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.47
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:58:32+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,110927000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:58:32+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,110927000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:58:32+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,110927000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:58:32+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10188000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:58:32+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,84631000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:58:32+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,94819000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:58:32+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,16108000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:58:32+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9746000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:58:32+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,989000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:58:32+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:58:32+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8757000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:58:32+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,7351000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:58:32+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:58:32+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7351000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:58:32+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7351000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:58:32+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:58:32+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7351000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:58:32+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,120989000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:58:32+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.06
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:58:32+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,123378000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:58:32+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.06
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:58:32+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,122500000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:58:32+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.06
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,186505000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,186505000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,186505000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,18042000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,101152000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,119194000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,67311000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,13917000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1560000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-12357000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,54954000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2933000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,52021000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,52021000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,52021000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,120933000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.43
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,120933000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.43
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,83900000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.21
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 21:34:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,115800000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 21:34:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,115800000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 21:34:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,115800000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 21:34:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,13677000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 21:34:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,82638000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 21:34:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,96315000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 21:34:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,19485000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 21:34:30+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11363000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 21:34:30+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2280000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 21:34:30+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1438000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 21:34:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10521000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 21:34:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,8964000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 21:34:30+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 21:34:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8964000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 21:34:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8964000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 21:34:30+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 21:34:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8964000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 21:34:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,122861000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 21:34:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.07
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 21:34:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,124972000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 21:34:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.07
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 21:34:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,128100000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 21:34:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.07
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:22:48+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,112273000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:22:48+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,112273000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:22:48+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,112273000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:22:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,22317000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:22:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,83506000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:22:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,105823000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:22:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6450000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:22:48+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11778000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:22:48+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2465000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:22:48+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:22:48+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9313000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:22:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2863000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:22:48+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,222000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:22:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3085000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:22:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3085000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:22:48+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:22:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3085000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:22:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,123989000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:22:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.02
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:22:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,123989000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:22:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.02
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:22:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,154300000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:22:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.02
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 14:46:10+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,118314000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 14:46:10+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,118314000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 14:46:10+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,118314000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 14:46:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,26788000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 14:46:10+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,80214000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 14:46:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,107002000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 14:46:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,11312000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 14:46:10+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10825000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 14:46:10+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2811000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 14:46:10+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-9830000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 14:46:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-17844000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 14:46:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6532000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 14:46:10+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,961000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 14:46:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7493000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 14:46:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7493000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 14:46:10+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-4882000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 14:46:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2611000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 14:46:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,124370000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 14:46:10+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.02
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 14:46:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,124370000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 14:46:10+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.02
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 14:46:10+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,261100000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 14:46:10+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.01
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,167792000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,167792000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,167792000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,45706000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,128286000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,173992000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6200000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10786000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,623000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,31000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10132000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16332000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-7163000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9169000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9169000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-6247000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2922000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,124016000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.12
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,126098000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.12
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2300000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.11
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:37:41+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,144419000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:37:41+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,144419000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:37:41+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:37:41+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,144419000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:37:41+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,43653000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:37:41+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,104067000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:37:41+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,147720000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:37:41+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3301000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:37:41+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10938000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:37:41+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3610000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:37:41+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-168000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:37:41+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-7496000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:37:41+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10797000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:37:41+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,15000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:37:41+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10812000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:37:41+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10812000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:37:41+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-9392000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:37:41+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1420000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:37:41+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,125330000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:37:41+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.01
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:37:41+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,125330000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:37:41+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.01
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:37:41+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,142000000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:37:41+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.01
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 18:33:49+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,117747000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 18:33:49+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,117747000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 18:33:49+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 18:33:49+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,117747000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 18:33:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,66198000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 18:33:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,101830000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 18:33:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,168028000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 18:33:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-50281000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 18:33:49+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11113000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 18:33:49+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,5137000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 18:33:49+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,45000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 18:33:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5931000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 18:33:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-56212000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 18:33:49+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,358000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 18:33:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-56570000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 18:33:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-56570000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 18:33:49+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-16215000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 18:33:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-40355000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 18:33:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,128712000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 18:33:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.29
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 18:33:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,128712000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 18:33:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.29
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 18:33:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,139200000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 18:33:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.29
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 15:42:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,145395000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 15:42:16+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,145395000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 15:42:16+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 15:42:16+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,145395000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 15:42:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,68712000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 15:42:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,95255000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 15:42:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,163967000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 15:42:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-18572000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 15:42:16+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11282000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 15:42:16+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,9963000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 15:42:16+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-22000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 15:42:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1341000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 15:42:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-19913000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 15:42:16+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,452000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 15:42:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20365000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 15:42:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20365000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 15:42:16+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-15806000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 15:42:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4559000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 15:42:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,137346000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 15:42:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.03
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 15:42:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,137346000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 15:42:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.03
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 15:42:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,152000000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 15:42:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.03
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,192113000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,192113000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1820000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1820000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,190293000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,66059000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,113452000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,179511000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,10782000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11456000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,11477000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-37000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-16000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,10766000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-291966000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,302732000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,302732000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-17343000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,320075000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,132320000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.42
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,134056000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.4
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,131000000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.42
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:03:32+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,297214000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:03:32+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,297214000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:03:32+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1041000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:03:32+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1041000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:03:32+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,296173000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:03:32+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,68221000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:03:32+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,106417000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:03:32+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,174638000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:03:32+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,121535000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:03:32+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11599000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:03:32+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,12142000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:03:32+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-147000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:03:32+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,396000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:03:32+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,121931000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:03:32+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,31047000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:03:32+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,90884000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:03:32+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,90884000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:03:32+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,6441000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:03:32+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,84443000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:03:32+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,138582000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:03:32+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.63
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:03:32+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,141537000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:03:32+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.62
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:03:32+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,134000000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:03:32+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.63
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 18:33:49+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,163813000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 18:33:49+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,163813000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 18:33:49+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1364000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 18:33:49+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1364000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 18:33:49+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,162449000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 18:33:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,75111000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 18:33:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,106165000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 18:33:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,181276000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 18:33:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-18827000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 18:33:49+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11802000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 18:33:49+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,13735000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 18:33:49+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-45000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 18:33:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1888000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 18:33:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16939000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 18:33:49+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-6927000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 18:33:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10012000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 18:33:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10012000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 18:33:49+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-9136000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 18:33:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-876000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 18:33:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,140247000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 18:33:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.01
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 18:33:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,140247000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 18:33:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.01
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 18:33:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,87600000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 18:33:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.01
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 15:42:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,167892000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 15:42:16+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,167892000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 15:42:16+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,967000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 15:42:16+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,967000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 15:42:16+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,166925000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 15:42:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,60036000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 15:42:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,104366000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 15:42:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,164402000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 15:42:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2523000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 15:42:16+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,12002000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 15:42:16+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,13136000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 15:42:16+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-140000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 15:42:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,994000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 15:42:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3517000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 15:42:16+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-14915000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 15:42:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,18432000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 15:42:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,18432000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 15:42:16+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-7732000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 15:42:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,26163000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 15:42:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,140551000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 15:42:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.19
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 15:42:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,143408000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 15:42:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.18
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 15:42:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,137700000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 15:42:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.19
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,493680000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,493680000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q4,2019-10-01,2019-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1012000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1012000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,492668000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,83276000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,148740000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,232016000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,260652000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,35230000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,13192000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-354000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-22392000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,238260000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,34302000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,203958000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,203958000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,19543000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,184416000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,139998000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.31
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,142872000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.29
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,138700000.0
Ionis Pharmaceuticals Inc,IONS,549300SI4ZGLG0BLUZ92,0000874015,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.31
